Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Benign prostatic hyperplasia Age: Adult |
Dose: Oral – 500 mcg Frequency: once daily Duration: for at least 6 months |
|
Indication: Benign prostatic hyperplasia Age: Adult Condition: Severe Hepatic impairment |
Dose: Oral Note: Contraindicated |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: Not recommended |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not applicable – Dose adjustment not necessary Note: Renal impairment: Dose adjustment not necessary |
Administration
- Take with or without food
- Take once daily
Side Effect
- Impotence
- Decreased libido
- Ejaculation disorder
- Breast disorders/gynecomastia
- Dizziness
- Cardiac failure
- Prostate cancer (high grade)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors
|
May increase plasma concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe Liver Impairment
|
Can worsen liver function
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.